SE0000178D0 - Protein purification I - Google Patents

Protein purification I

Info

Publication number
SE0000178D0
SE0000178D0 SE0000178A SE0000178A SE0000178D0 SE 0000178 D0 SE0000178 D0 SE 0000178D0 SE 0000178 A SE0000178 A SE 0000178A SE 0000178 A SE0000178 A SE 0000178A SE 0000178 D0 SE0000178 D0 SE 0000178D0
Authority
SE
Sweden
Prior art keywords
protein purification
iii
gel
isoform
preparation
Prior art date
Application number
SE0000178A
Other languages
English (en)
Swedish (sv)
Inventor
Stefan Winge
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE0000178A priority Critical patent/SE0000178D0/xx
Publication of SE0000178D0 publication Critical patent/SE0000178D0/xx
Priority to DK01942635.2T priority patent/DK1248796T3/da
Priority to EP01942635A priority patent/EP1248796B1/fr
Priority to CA002395489A priority patent/CA2395489A1/fr
Priority to JP2001553800A priority patent/JP4897177B2/ja
Priority to AU28984/01A priority patent/AU778915C/en
Priority to ES01942635T priority patent/ES2361492T3/es
Priority to DE60144221T priority patent/DE60144221D1/de
Priority to AT01942635T priority patent/ATE502044T1/de
Priority to PT01942635T priority patent/PT1248796E/pt
Priority to EP10179443A priority patent/EP2284187A3/fr
Priority to PCT/SE2001/000084 priority patent/WO2001053328A1/fr
Priority to US09/766,887 priority patent/US6451978B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE0000178A 2000-01-21 2000-01-21 Protein purification I SE0000178D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE0000178A SE0000178D0 (sv) 2000-01-21 2000-01-21 Protein purification I
PCT/SE2001/000084 WO2001053328A1 (fr) 2000-01-21 2001-01-18 Processus de purification d'antithrombotique iii
JP2001553800A JP4897177B2 (ja) 2000-01-21 2001-01-18 抗トロンビンｉｉｉの精製の方法
EP01942635A EP1248796B1 (fr) 2000-01-21 2001-01-18 Procédé de purification d'antithrombine-iii
CA002395489A CA2395489A1 (fr) 2000-01-21 2001-01-18 Processus de purification d'antithrombotique iii
DK01942635.2T DK1248796T3 (da) 2000-01-21 2001-01-18 Fremgangsmåde til oprensning af antithrombin-III
AU28984/01A AU778915C (en) 2000-01-21 2001-01-18 Process for the purification of antithrombin-III
ES01942635T ES2361492T3 (es) 2000-01-21 2001-01-18 Procedimiento para la purificación de antitrombina-iii.
DE60144221T DE60144221D1 (de) 2000-01-21 2001-01-18 Verfahren zur reinigung von antithrombin-iii
AT01942635T ATE502044T1 (de) 2000-01-21 2001-01-18 Verfahren zur reinigung von antithrombin-iii
PT01942635T PT1248796E (pt) 2000-01-21 2001-01-18 Processo de purifica??o de antitrombina-iii
EP10179443A EP2284187A3 (fr) 2000-01-21 2001-01-18 Procédé pour la purification de l'antithrombine III
US09/766,887 US6451978B2 (en) 2000-01-21 2001-01-19 Purification of antithrombin-III-α and β

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000178A SE0000178D0 (sv) 2000-01-21 2000-01-21 Protein purification I

Publications (1)

Publication Number Publication Date
SE0000178D0 true SE0000178D0 (sv) 2000-01-21

Family

ID=20278172

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0000178A SE0000178D0 (sv) 2000-01-21 2000-01-21 Protein purification I

Country Status (11)

Country Link
EP (2) EP2284187A3 (fr)
JP (1) JP4897177B2 (fr)
AT (1) ATE502044T1 (fr)
AU (1) AU778915C (fr)
CA (1) CA2395489A1 (fr)
DE (1) DE60144221D1 (fr)
DK (1) DK1248796T3 (fr)
ES (1) ES2361492T3 (fr)
PT (1) PT1248796E (fr)
SE (1) SE0000178D0 (fr)
WO (1) WO2001053328A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000177D0 (sv) * 2000-01-21 2000-01-21 Pharmacia & Upjohn Ab Protein purification II
WO2004092218A1 (fr) * 2003-04-17 2004-10-28 Mitsubishi Pharma Corporation Procede d'elaboration d'antithrombine de recombinaison
EP1987054A1 (fr) * 2006-01-25 2008-11-05 Octapharma AG Purification et utilisation d'un facteur favorisant la cicatrisation des blessures
EP2141178A4 (fr) 2007-04-02 2010-05-19 Kyowa Hakko Kirin Co Ltd Procédé de production de composition d'antithrombine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3519011A1 (de) * 1985-05-25 1986-11-27 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines materials zur affinitaetschromatographie
DE3811042A1 (de) 1988-03-31 1989-10-19 Merck Patent Gmbh Ionenaustauscher

Also Published As

Publication number Publication date
WO2001053328A1 (fr) 2001-07-26
AU778915B2 (en) 2004-12-23
EP1248796A1 (fr) 2002-10-16
EP1248796B1 (fr) 2011-03-16
PT1248796E (pt) 2011-05-26
DK1248796T3 (da) 2011-07-11
AU2898401A (en) 2001-07-31
EP2284187A2 (fr) 2011-02-16
ES2361492T3 (es) 2011-06-17
JP2003520805A (ja) 2003-07-08
DE60144221D1 (de) 2011-04-28
CA2395489A1 (fr) 2001-07-26
JP4897177B2 (ja) 2012-03-14
AU778915C (en) 2005-06-23
EP2284187A3 (fr) 2011-06-22
ATE502044T1 (de) 2011-04-15

Similar Documents

Publication Publication Date Title
FI971746A (fi) Booriesteri- ja -happoyhdisteet sekä näiden synteesi ja käyttö
DK1561768T3 (da) Polyarylenæterforbindelse indeholdende sulfonsyregrupper, sammensætning indeholdende den samme og fremgangsmåde til fremstilling af disse
ES2178779T3 (es) Nuevas amidas de acidos de piridil alcanos como agentes citoestaticos e inmunosupresores.
DE60225174D1 (de) Beta-3 adrenergische agonisten
ATE262519T1 (de) Heterozyklische ether- und thioether-verbindungen,verwendbar zur steuerung von chemischer synaptischer transmission
ATE288900T1 (de) Substituierte benzoylcyclohexandione
BR0206501A (pt) Inibidores de cruzipaìna e outras cisteìna proteases
RS51512B (sr) Postupak za prečišćavanje interferonskih proteina pomoću katjonske izmenjivačke hromatografije
BR9714650A (pt) " derivados farmacêuticos de ácido aminofosfÈnico "
BR0317678A (pt) Piridodiazinas como fungicidas de planta
SE0000178D0 (sv) Protein purification I
DE69009267D1 (de) Kombiniertes Wärmeaustauschsystem für Reaktionsströme der Ammoniaksynthese.
PT1122245E (pt) 2-amino-benzoxazinonas para o tratamento de infeccoes virais
ATE250021T1 (de) Hydroxycyclopentanone
NO904576D0 (no) Aminopyridinylaminofenol og beslektede forbindelser, mellomprodukter, fremgangsmaate for deres fremstilling og anvendelse som medikamenter.
DE60334548D1 (en) Teststück fur proteinassay
NO20020425D0 (no) Nye naftylsulfonsyrer og beslektede forbindelser som glukoseopptaksagonister
ES2021055B3 (es) Polimerizacion de transferencia de grupos catalizada por compuestos de mercurio.
DK0937043T3 (da) Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater
BR0209159A (pt) Misturas sólidas de derivados de alfa-hidroxicarbonila de oligÈmeros de alfa-metilestireno, e, processo para a preparação e uso das mesmas
BR0108409A (pt) Derivados de aminoácidos e sua utilização como inibidores da nep, da ace e da ece
DE3765765D1 (de) Polymere als beizmittel fuer saure farbstoffe.
BR0211737A (pt) Derivados fenìlicos como inibidores do fator xa
BRPI0415497A (pt) composto processo para a sua preparação , composição farmacêutica que compreende o mesmo, utilização de um composto e método para o tratamento de diabetes do tipo ii
BR9813897A (pt) Derivados de bifenila como farmacêuticos